Pharmacists and healthcare industry leaders Rob ‘Hoopi’ Nahoopii PharmD, MS, ACE and Greg Wilson PharmD, BCPS, ACE dive deeply into the complicated and contentious 340B Program as well as other pressing Pharmacy matters. Special guests and industry experts pop in frequently to add insights from all sides of the discussion. If you serve in the pharmacy sector, this podcast is a must-listen!
…
continue reading
340B Insight provides members and supporters of 340B Health with timely updates and discussions about the 340B drug pricing program. The podcast helps listeners stay current with and learn more about 340B to help them serve their patients and communities and remain compliant. We publish new episodes twice a month, with news reports and in-depth interviews with leading health care practitioners, policy and legal experts, public policymakers, and our expert staff.
…
continue reading
Maintaining a compliant 340B Program can be daunting and complex. Staying current with the latest clinical, pharmaceutical and industry related news is essential in order to make informed decisions and provide the best care possible. Listen to leading 340B, technology and pharmacy professionals who provide clinical insights and the latest information to help support your 340B program. Learn more at 340BInsider.com
…
continue reading
The world of 340B has seen significant developments on the state and national levels in recent months. A second federal appeals court decision on 340B contract pharmacies came down in recent weeks, a new bill in Congress threatens to impose significant restrictions on hospital participation in 340B program, and more states move to protect covered e…
…
continue reading
1
Ep 47 | Alternate Distribution Models & 340B
55:07
55:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
55:07
In this episode, Greg and Rob are joined by a new SpendMend team member – Nick Gnadt – to discuss considerations around the use of alternate distribution models (ADMs) in the 340B space. They discuss some of the practical considerations around implementing ADM, where there may be operational or regulatory challenges, and what the long-term outlook …
…
continue reading
1
How To Navigate the 340B ADR Process
21:29
21:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:29
The finalized 340B administrative dispute resolution (ADR) rule is set to go into effect on June 18 and will create a process to settle certain disputes between covered entities and drug manufacturers. But what should covered entities know about this process before it launches? Jason Reddish, a 340B expert with the Powers Pyles Sutter & Verville he…
…
continue reading
1
Ep 46 | Revisiting the Intersection of the IRA Medicare Drug Pricing Program & 340B – Conversation with Jeff Davis
53:12
53:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
53:12
In this episode, Greg and Rob welcome back health care attorney Jeff Davis to catch up on the latest draft guidance published by CMS to address IRA-mandated Medicare drug pricing provisions and impact to 340B providers (15:25). Additionally, they chat about the 340B ACCESS Act, a new piece of draft legislation introduced in the House with sweeping …
…
continue reading
In this episode, Greg and Rob are joined by healthcare attorney Ross Marguiles to discuss how a Supreme Court ruling on litigation in the fishing industry could have a major impact on the healthcare landscape. Ross provides background on Chevron deference, a 40-year judicial doctrine that allows courts to defer ruling to federal administrative agen…
…
continue reading
1
How 340B Savings Can Help Hospitals Take Their Care on the Road
21:53
21:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:53
Hospitals throughout the U.S. use their 340B savings in innovative ways to care for their patients in need. In some cases, they can take that care outside the walls of the hospital to meet patients where they learn, live, and play. We speak with Heather Armstrong with Comanche County Medical Center in central Texas to tell us how her health system …
…
continue reading
1
Ep 44 | Pharmacotherapy Clinic Services & 340B
53:22
53:22
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
53:22
In this episode, SpendMend colleague Matt Parker joins Greg and Rob (14:00) to discuss pharmacotherapy services, and how pharmacist-driven care can help promote improved health outcomes in a community, as well as how these services might intersect with a covered entity’s 340B Program. They highlight the clinical and financial benefits that these se…
…
continue reading
340B savings can help hospitals and other covered entities better serve patients and improve their health outcomes. But how can these entities make the best use of 340B funds for their institutions? We sat down with Matt Webber, director of pharmacy business at Novant Health based in North Carolina, to learn more. 340B optimization strategies One w…
…
continue reading
1
Ep 43 | Getting to Know the HRSA DRL – DRL 8 Self-Disclosure Documentation and DRL 9 Medicaid Billing Information
51:10
51:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
51:10
In this episode, Greg and Rob continue to provide insights on the HRSA data request list. DRL #8 is self-disclosure documentation and DRL #9 is Medicaid billing information, which includes providing details regarding your CE’s listing on the Medicaid Exclusion File, as well as sample billing claim forms for physician-administered drugs and billing …
…
continue reading
1
New Federal and State Legislative Movement on 340B
21:51
21:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:51
The 340B community has seen major activity on several fronts since the start of 2024 – the introduction of new legislation on Capitol Hill, movement on legislation in the states, and key developments in the courts. 340B Health President and CEO Maureen Testoni returns to the show to help us make sense of these developments and how they might affect…
…
continue reading
1
Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 2
44:43
44:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
44:43
SpendMend colleagues Jasmine and Megan continue their conversation providing some grantee CE perspectives concerning the HRSA DRL.بقلم SpendMend Pharmacy
…
continue reading
1
Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1
48:48
48:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
48:48
In this episode, SpendMend colleagues Jasmine and Megan provide some grantee CE perspectives concerning the HRSA DRL. They have so much great insight, we are breaking this conversation up into two parts. Stay tuned for Part 2 next week! In the intro, Rob and Greg discuss thoughts around responding to manufacturer 340B inquiries.…
…
continue reading
1
How To Prevent 340B Duplicate Discounts
22:34
22:34
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
22:34
One of the most important elements of 340B compliance is preventing duplicate discounts. Ensuring there are no duplicate discounts is high on the list of compliance concerns for covered entities, and it is one of the major items that 340B auditors look for. But how do these entities ensure they stay compliant? On this episode, we speak to Melissa B…
…
continue reading
In this episode, Rob and Greg catch up on a cluster of developments in the 340B space, including updates to manufacturer contract pharmacy restrictions, thoughts on a federal appellate court ruling on Arkansas' contract pharmacy law, a preliminary take on the 340B PATIENTS Act recently introduced by Rep. Doris Matsui (D-CA), and an update on ongoin…
…
continue reading
1
Exploring the Legal and Legislative Landscape of 340B with Ted Slafsky
23:47
23:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
23:47
In this podcast episode, we are joined by Ted Slafsky, Publisher and CEO of the 340B Report and Founder & Principal of Wexford Solutions LLC. During our discussion, Ted highlights ongoing federal court decisions and updates listeners on states like Arkansas and Louisiana, where laws restoring 340B pricing have faced legal challenges but are making …
…
continue reading
1
How Do 340B Child Site Eligibility Changes Affect Hospitals?
16:29
16:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
16:29
340B hospitals can register certain outpatient locations with the Health Resources & Services Administration (HRSA) as 340B child sites, which allows them to use 340B drugs. HRSA recently announced some changes to how it had been determining this eligibility during the COVID-19 public health emergency. How have these changes affected 340B hospitals…
…
continue reading
1
Ep 40 | Getting to Know the HRSA DRL: DRL 5 Purchasing Documentation and DRL 7 Entity-Owned Pharmacy Documentation
48:20
48:20
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
48:20
In this episode, Greg and Rob continue reviewing data solicited by HRSA during an audit. DRL #5 is purchasing documentation, including a list of accounts, sample invoices, and 340B purchase order details. This ends up being a labor-intensive section to complete for HRSA, especially for larger organizations with a variety of purchasing practices. DR…
…
continue reading
The Health Resources & Services Administration audits 200 covered entities each year for compliance with 340B rules. We speak with Mark Capuano, senior director of the corporate pharmacy 340B program at New York City Health and Hospitals, about what hospitals should expect when they find out they will be going through a 340B audit. How a hospital c…
…
continue reading
1
Ep 39 | A Revisit of Ongoing Contract Pharmacy Restrictions
32:39
32:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
32:39
In this episode, Greg and Rob are once again joined by SpendMend team member Riley Protz, to catch up on the current state of ongoing manufacturer restrictions on 340B contract pharmacy operations, as well as to offer insights on various mitigation strategies, like the opportunity for grantee CEs to make associated site contract pharmacy designatio…
…
continue reading
1
How New 340B Reporting Requirements Are Affecting Hospitals
17:40
17:40
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
17:40
340B sits at an intersection where federal programs and state agencies come together. Maine, Minnesota, and Washington recently enacted new laws requiring hospitals to report 340B information to the states each year. What should health systems know about these new requirements? We speak with Danny Ackert, the director of state government relations …
…
continue reading
1
Ep 38 | Getting to Know the HRSA DRL: DRL 4 Provider List and DRL 6 Contract Pharmacy Documentation
1:04:50
1:04:50
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:04:50
In this episode, Greg and Rob continue their review of items from the HRSA audit data request list (DRL). They’ll cover DRL #4, the provider list, as well as DRL #6, contract pharmacy documentation. Don’t worry – they’ll come back to DRL #5 (purchasing documentation) in an upcoming episode! In the intro, Rob shares a few insights from the recent 34…
…
continue reading
1
Answering More of Your 340B Questions
18:35
18:35
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
18:35
We are returning to a popular episode format we aired early last year, when we consulted with 340B Health’s expert staff to answer your most pertinent 340B questions. As we start another busy year for 340B, we help you prepare for the action by answering your questions about the Genesis court decision, 340B activity in state legislatures, Medicare …
…
continue reading
1
Ep 37 | Getting to Know HRSA DRL: Part 3 - 340B Universe Data
1:06:51
1:06:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:06:51
In this episode, Greg and Rob continue to cover the HRSA data request list, focusing this week on DRL item #3, probably the most complex of all of the sections – 340B universe data. They’ll talk about tips for organizing your 340B utilization data for an HRSA audit, and share insights regarding what the HRSA audit experience might be like when revi…
…
continue reading
1
Ep 36 | Getting to Know HRSA DRL: Part 2 - CE Eligibility Documentation
43:32
43:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
43:32
In Episode 36, Greg and Rob provide updates on recent 340B news around state legislation, manufacturer restrictions, and HRSA's decision to not appeal the Genesis case court ruling. They also provide insight and thoughts around the HRSA data request list item 2, the covered entity eligibility documentation. Also, if you are at 340B Winter Coalition…
…
continue reading
1
Advice for 340B Hospitals Pursuing Health Equity
18:58
18:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
18:58
Episode Description: The 340B drug pricing program can produce significant savings that hospitals can invest in more equitable care for underserved patients. What are some of the best ways for hospitals to use their savings in the pursuit of greater health equity? We sit down with Danielle McPherson, the executive director of managed care contracti…
…
continue reading
1
Major New Developments End an Exciting Year for 340B
21:58
21:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:58
The past several months have seen several major developments in the world of 340B drug pricing. 340B Health President and CEO Maureen Testoni returns to the show to break down some of the most important recent 340B stories. Landmark Federal Court Ruling on Patient Definition In November, a federal court in South Carolina ruled against the Health Re…
…
continue reading
1
Ep 35 | Top 10 Developments in 340B for 2023
1:05:01
1:05:01
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:05:01
For our last episode of 2023, Greg and Rob reviewed hot topics impacting 340B covered entities from the past year.بقلم SpendMend Pharmacy
…
continue reading
1
Navigating the Complexities of 340B: Insights from a Pharmacist and Founder
18:15
18:15
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
18:15
In this episode of the RxStrategies 340B Insider Podcast, hosts Jonathan Ghenn and Rhodie Smith engage in a conversation with Rob Johnson, a pharmacist and entrepreneur who founded RPh Innovations, a company providing professional support services to 340B covered entities. Rob shares insight into the evolving dynamics of the 340B program over his y…
…
continue reading
1
Ep 34 | Maintaining 340B Compliance: The Importance of Self-Auditing
44:58
44:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
44:58
In this episode, Greg and Rob are joined by Spendmend colleague Cat Eriksen (16:11) to discuss the importance of self-auditing as part of a 340B covered entity’s overall compliance strategy. They’ll talk about HRSA standards around self-auditing, how some hospitals and clinics struggle to prioritize this effort, and why seeking external support to …
…
continue reading
1
Ep 33 | Thoughts on the Genesis v. Becerra Court Ruling
38:53
38:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
38:53
In this episode, Rob and Greg share thoughts from the recent federal court ruling on the Genesis v Becerra case, which focuses on patient definition. Additionally, they catch up on manufacturer restriction changes and some developments from recent Senate HELP Committee 340B inquiries. If you are attending the ASHP Clinical Midyear meeting in Anahei…
…
continue reading
1
How To Engage Your Leadership on 340B
21:41
21:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:41
In July, Karen Bowling became the new chair of the 340B Health Board of Directors. The West Virginia native is the president and CEO of Princeton Community Hospital and executive vice president of government affairs for West Virginia University Health System (WVU Medicine). In this episode, Bowling discusses her clinical and leadership experience, …
…
continue reading
1
Ep 32 | Getting to Know the HRSA DRL: Part 1 – Policies & Procedures
58:56
58:56
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
58:56
This episode is the first part of a series of recordings we are putting together to review the HRSA data request list (DRL). Rob and Greg discuss DRL item #1 – 340B Policies and Procedures. They’ll review the types of operations that HRSA expects to see outlined in a covered entity’s 340B policies and share some insights into how to manage these do…
…
continue reading
1
340B in the States: 2023 State Legislative Recap and 2024 Outlook
18:13
18:13
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
18:13
This week we are joined by Amanda Sellers Smith, legal counsel for 340B Health. Amanda tracks and responds to 340B state legislative and regulatory actions. She discusses recent developments in state-based legislation, including 340B reporting requirements, nondiscrimination prohibitions, and bans on drugmaker restrictions. She also looks ahead to …
…
continue reading
1
Bonus Ep 2 | HRSA Notice Addressing 340B Registration Requirements
24:47
24:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
24:47
In this bonus episode, Rob and Greg review the HRSA notice published on October 27 that addresses the immediate use of 340B drugs in unregistered locations and some hospital considerations in response to the update.بقلم SpendMend Pharmacy
…
continue reading
1
Ep 31 | Answering 340B FAQs - Rob vs. ChatGPT
1:02:37
1:02:37
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:37
In this episode, Rob is pitted against ChatGPT to answer 340B-related FAQs, including topics like child site registration, GPO prohibition, and HRSA audit findings (17:29). In the intro, Greg and Rob catch up on revised contract pharmacy restrictions and thoughts on recent manufacturer inquiries that 340B entities have been receiving. Email us ques…
…
continue reading
1
How Centralized Distribution Affects Healthcare
16:58
16:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
16:58
Centralized distribution models can help health systems streamline day-to-day operations, including mitigating drug shortages, and maximizing contract compliance and efficiency. Jake Olson, 340B pharmacy manager at Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, joins us to discuss how centralized distribution models have operationali…
…
continue reading
1
Ep 30 | Turnkey Pharmacy Solutions, Whiteboards & 340B Stuff
1:07:46
1:07:46
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:07:46
Rich Bucher, one of the co-founders of Turnkey Pharmacy Solutions, makes a long-awaited appearance on the podcast with Greg and Rob. Rich and Rob share anecdotes from their early days getting involved in external 340B support (23:26). Rich also shares some thoughts on 340B topics like GPO Prohibition mitigation strategies (39:13), what to make of t…
…
continue reading
1
340B Legislative and Regulatory Update from Maureen Testoni
20:59
20:59
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
20:59
Several key developments in 340B-related legislation and regulation have occurred in recent weeks, and more are expected this fall. In this episode, Maureen Testoni returns to the show to give her updates on where 340B stands in Congress, in state legislatures, and with the administration. State Legislation Testoni notes how states such as Arkansas…
…
continue reading
1
Ep 29 | The Intersection Between the Inflation Reduction Act (IRA) & 340B – Conversation with Jeff Davis
1:09:11
1:09:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:09:11
In this episode, Greg and Rob are joined by healthcare attorney Jeff Davis, to discuss how the Medicare drug pricing provisions in the IRA will impact 340B providers. They’ll go over CMS billing modifier requirements (15:27), share opinions on the financial impact covered entities might experience (38:02), and how various legal challenges to the IR…
…
continue reading
340B compliance is essential to the integrity and success of the program, and data management across hospital departments is an essential element of compliance. By implementing data crosswalks, 340B hospitals can achieve greater program compliance and optimization. Anja Wilkinson, 340B program manager at St. Francis Health System in Tulsa, Okla., j…
…
continue reading
1
Ep 28 | 340B Conversation with Emily Cook - Part 2
50:13
50:13
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
50:13
Rob and Greg continue their conversation with health care attorney and 340B expert Emily Cook (21:05). They discuss thoughts on the CMS Medicare Part B remedy, provide some commentary on the Inflation Reduction Act (IRA) and its intersection with 340B covered entities, and address an issue that could impact hospital DSH eligibility in the future. I…
…
continue reading
1
The Inflation Reduction Act's Impact on 340B
16:55
16:55
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
16:55
The Inflation Reduction Act (IRA) was enacted last year, and it includes a significant drug pricing component that will affect 340B savings on some of the drugs that cost the most for Medicare. In this episode, we are joined by Meetali Desai, director of pharmacy business services at UMass Memorial Medical Center, to discuss the impact of the IRA o…
…
continue reading
1
Ep 27 | 340B Conversation with Emily Cook - Part 1
1:08:21
1:08:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:08:21
Rob and Greg are joined by Emily Cook (20:15), an attorney in the health care and 340B space. They discuss a number of 340B topics, including ongoing manufacturer restrictions of contract pharmacies (24:52) as well as legal challenges to HRSA’s patient definition (42:16). This is part one of a two-part series, so look for a future podcast episode w…
…
continue reading
1
340B Insights: How to Optimize a Mixed Use Program
15:09
15:09
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
15:09
Optimizing a mixed-use program, particularly in the complex landscape of 340B, requires a strategic approach. To ensure compliance, maximize savings, and streamline operations, there are a few key components to consider. In this episode, we are joined by Austin Shady, a Senior Director of Client Success at RxStrategies. After receiving a Master's i…
…
continue reading
1
Annual 340B Recertification Is Here!
19:21
19:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
19:21
It’s that time of year again when your 340B hospital must go through the annual 340B recertification process. 340B Health’s vice president of pharmacy services Steven Miller joins us to discuss what 340B covered entities need to know about recertification and how to recertify without any errors. How the Recertification Process Works Steve explains …
…
continue reading
1
Ep 26 | First Year Anniversary of the 340B Unscripted Podcast - Q & A Session
1:05:31
1:05:31
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:05:31
Aiden shares the 340B questions sent in by our listeners, and there are some good ones. Questions include opening an in-house retail pharmacy, CAR-T therapy, continuum of care and 190 clinics, the IRA, and a couple of other fun ones. On our one-year anniversary, we want to thank everyone for listening and for all the encouragement we have received.…
…
continue reading
Cindy Williams has critical advice for anyone wanting to start a career in 340B and pharmacy. Cindy is the vice president and chief pharmacy officer at Riverside Health System in Virginia. In this episode, she walks us through her 340B professional journey over the last three decades, from her initial dreams of having a career in health care to a l…
…
continue reading
1
Ep 25 | 340B Coalition Summer Conference Recap - Part 2
1:33:30
1:33:30
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:33:30
Rob and Greg continue to unpack all the great information gathered from the 2023 340B Coalition Summer Conference in Washington D.C. They chat with coworkers, clients, and friends in the 340B community to share insights from sessions at the Conference. Guests include SpendMend colleagues Jennifer Hagen (16:54) and Shakita Carter (38:12), as well as…
…
continue reading
1
Ep 24 | 340B Coalition Summer Conference Recap
54:19
54:19
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
54:19
Greg and Rob share highlights from the 340B Coalition Conference in DC. Topics covered include proposed CMS repayment for affected hospitals, Inflation Reduction Act updates, legislative updates, and other worthy conference discussions.بقلم SpendMend Pharmacy
…
continue reading
1
The Biggest Trends in Specialty Pharmacy
19:13
19:13
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
19:13
Specialty pharmacy trends have evolved significantly in recent years and even in the past few months. In this episode, Tim Paine, a specialty pharmacy expert who now heads up EPU Healthcare Consulting, dives into specialty pharmacy and its connection to the 340B program. Building off his decades of experience in pharmaceuticals and pharmacy, Tim di…
…
continue reading